[Capital FM] Nairobi — The COMESA Competition Commission has warned its member states against the sale of a false batch of cancer medicine identified as Herceptin 440 mg (Trastuzumab 440mg) reported to have penetrated the Kenyan market.
Source link : https://allafrica.com/stories/202405150136.html
Author :
Publish date : 2024-05-15 07:05:26
Copyright for syndicated content belongs to the linked Source.